Literature DB >> 2461711

Inhibition of atrial natriuretic peptide secretion by forskolin in noncontracting cultured atrial myocytes.

H Iida1, E Page.   

Abstract

Secretory rates for immunoreactive atrial natriuretic peptide (ANP) by 7 - 8 day-old primary cultures of atrial myocytes from adult rats (with myocyte contraction inhibited by tetrodotoxin (TTX)) were (a) constant for at least two hours, and (b) significantly slowed by forskolin (1, 5, and 25 microM), dibutyryl cyclic adenosine monophosphate (1 mM), or isobutylmethylxanthine (100 microM). The substantial rates of ANP secretion which persisted in cells rendered noncontracting either by inhibiting Ca2+ influx via reduction of external [Ca2+] to less than 10(-7) M or by inhibiting sarcoplasmic reticulum Ca2+ release with 100 microM ryanodine were significantly slowed by 25 microM forskolin, but forskolin sensitivity was lost by cells exposed simultaneously to external Ca2+ concentration of less than 10(-7) M and 100 microM ryanodine. Quiescent myocytes whose ANP secretory rate was depressed by forskolin remained responsive to secretory stimulation by phorbol ester.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2461711     DOI: 10.1016/s0006-291x(88)80051-2

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

1.  Localization of wheat-germ agglutinin-binding sites in the Golgi complex of cultured rat atrial myocytes.

Authors:  H Iida; E Page
Journal:  Cell Tissue Res       Date:  1989-08       Impact factor: 5.249

2.  VAMP-1, VAMP-2, and syntaxin-4 regulate ANP release from cardiac myocytes.

Authors:  Marcella Ferlito; William B Fulton; Mohamed A Zauher; Eduardo Marbán; Charles Steenbergen; Charles J Lowenstein
Journal:  J Mol Cell Cardiol       Date:  2010-08-27       Impact factor: 5.000

3.  Ethanol Extract of Lepidium apetalum Seed Elicits Contractile Response and Attenuates Atrial Natriuretic Peptide Secretion in Beating Rabbit Atria.

Authors:  Seung Ju Kim; Hye Yoom Kim; Yun Jung Lee; Hao Zhen Cui; Ji Yeon Jang; Dae Gill Kang; Ho Sub Lee
Journal:  Evid Based Complement Alternat Med       Date:  2013-10-29       Impact factor: 2.629

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.